Follow the CARsgen Therapeutics Holdings Ltd. - B stock price and the full insider trade history of the company, a listed equity based in Hong Kong. Shares trade on the HK market, under the supervision of HKEX. Market capitalisation: €7.7bn. The latest transaction was reported on 4 August 2026 (Sale). Among the most active insiders: Guo Huaqing. All data is free.
9
Insider Decl.
n/a
Thresholds
n/a
3 ops.
Buy Volume
n/a
6 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate CARsgen Therapeutics Holdings Ltd. - B Hold (neutral), based on 2 analysts. Average price target: HK$18.33.
Fundamental score
Ranked 23,070 of 28,932 companies
30.8
score / 100
Value
28
Quality
34
FCF yld-3.2%
Earn yld-1.3%
EV/EBITDA·
ROE-9.6%
Gross mgn64%
Net mgn-78%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
CARsgen Therapeutics Holdings Ltd. is a biopharmaceutical company focused on developing cell therapies for cancer treatment. It specializes in CAR-T technologies to enhance patient outcomes.